The size of the European scar treatment market was valued at USD 5.48 billion in 2022. It is projected to reach USD 8.80 billion by 2027, growing at a CAGR of 9.91%.
An increase in disposable income and a growth in appearance consciousness and awareness of scar treatments are majorly driving the Scar treatment market in the Western European region. Also, with increased pollution and UV radiation, skin disorders are rising, resulting in sunburns and a loss of skin suppleness that influences the market growth. In addition, with the increased prevalence of chronic wounds and the availability of various types of tropical scar treatment products, topical scar treatment is predicted to expand the most in the European scar treatment market during the forecast period. However, in the recent period, the Scare treatment is becoming increasingly popular, which is moving the market forward.
Other factors such as technological improvements, increasing investment, and government funding are anticipated to fuel the growth rate of the European scar treatment market. Surface scar treatment, laser treatment, injectable scar treatment, and invasive surgical scar treatment are all alternatives after tropical scar treatment. In Europe, post-surgical scars have been the most commonly treated scar type, followed by acne, keloid, hypertrophic, contracture, and stretch marks. Hospitals contributed the most to the European scar treatment market, owing to the region’s constantly evolving reimbursement framework. Furthermore, the region’s significant growth in the cosmetics business contributes to expanding the scar treatment market in Europe.
However, the adverse effects of scar treatment products and the high cost of these treatments are impeding the growth of the European scar treatment market.
This research report on the European scar treatment market has been segmented and sub-segmented into the following categories:
By Treatment Type:
By Scar Type:
By End User:
Geographically, the European scar treatment market was the second-largest regional market globally in 2020. The market is expected to account for a significant global market share during the forecast period. The tremendous interest in cosmetics treatments and novel treatment processes using modern technology that shortens the recuperation period increases market growth. According to the European Wound Management Association (EWMA), almost 4 million wound cases are registered annually in Europe.
Technological improvements and increased awareness about skin-related disorders and accessible treatments also drive the European scar treatment market forward. For instance, Lumenis Ltd. Sponsored the International Scar Treatment Conference in Israel in February 2017, which was held in Tel Aviv and focused on raising awareness about the importance of an interdisciplinary approach to scar management.
The scar treatment market in the UK is expected to lead the European market from 2022 to 2027. Increased knowledge of skin-related diseases, existing treatments, and innovative laser therapies drive greater demand for scar treatments in the United Kingdom.
The German scar treatment market is predicted to be another lucrative regional market in the European region. This increased disposable income allows consumers to choose new and expensive treatments and expand the online cosmetic products business to enhance market growth.
KEY MARKET PLAYERS:
A few of the prominent companies operating in the European scar treatment market profiled in this report are Oculus Innovative Sciences Inc, Smith & Nephew PLC, Nutramarks Inc, Merz Inc, Enaltus LLC, CCA Industries Inc, Cynosure IncLumenis, Syneron Medical Ltd, Mölnlycke Health Care, Avita Medical Limited, Pacific World Corporation, Shanghai Fosun Pharmaceuticals Ltd, AC. Alma Lasers, Valeant Pharmaceuticals International Inc., and Beijing Toplaser Technology Company Limited.
The European scar treatment market is expected to grow at a CAGR of 9.91% from 2022 to 2027.
Germany, France, the United Kingdom, Italy, and Spain are some of the major countries playing a leading role in the European scar treatment market.
Smith & Nephew plc, Merz Pharma GmbH & Co. KGaA, Lumenis Ltd., and Scarguard Labs, LLC. are some of the leading companies in the European scar treatment market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com